Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Ret proto-oncogene mutations associated with type 2 multiple endocrine neoplasms (MEN 2). Clinical implications].

Acta medica portuguesa - 1 Jan 2000

Bugalho M J, Sobrinho L G

Abstract excerpt

Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer syndrome. Clinical features and diagnostic aspects of this syndrome are reviewed with a focus on progress biochemical screening to genetic analysis of those at risk. The clinical implications resulting from the application of the new methods of molecular biology are discussed.

Topics

Drosophila Proteins
Humans
Multiple Endocrine Neoplasia Type 2a
Mutation
Proto-Oncogene Mas
Proto-Oncogene Proteins
Proto-Oncogene Proteins c-ret
Receptor Protein-Tyrosine Kinases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 7484255

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-7484255-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Ret proto-oncogene mutations associated with type 2 multiple endocrine neoplasms (MEN 2). Clinical implications].PMID 7484255Read ↗

[Multiple endocrine neoplasia: a clinical model for applying molecular genetic techniques].Semantic proximity Read ↗

[Multiple endocrine neoplasia type 2].Semantic proximity Read ↗

[Clinical features and mutations of RET proto-oncogene in a pedigree affected with type 2A multiple endocrine neoplasia].Semantic proximity Read ↗

Multiple endocrine neoplasia type 2: A review.Semantic proximity Read ↗

[The molecular pathology of RET protooncogene in families with multiple endocrine neoplasia type 2A].Semantic proximity Read ↗

RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.Semantic proximity Read ↗

Molecular diagnosis of multiple endocrine neoplasia Type 2.Semantic proximity Read ↗

[Multiple endocrine neoplasia type 2].Semantic proximity Read ↗

Utility of RET mutation analysis in multiple endocrine neoplasia type 2.Semantic proximity Read ↗

Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.Semantic proximity Read ↗

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Semantic proximity Read ↗

Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.